Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Antti Turunen, Jaakko Valtola, Anu Partanen, Antti Ropponen, Outi Kuittinen, Hanne Kuitunen, Kaija Vasala, Lasse Ågren, Karri Penttilä, Leena Keskinen, Eeva-Riitta Savolainen, Marja Pyörälä, Taru Kuittinen, Tuomas Selander, Pentti Mäntymaa, Jukka Pelkonen, Esa Jantunen & Ville Varmavuo. (2020) Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study. Leukemia & Lymphoma 61:9, pages 2082-2092.
Read now
Read now
Esa Jantunen, Ville Varmavuo & Jaakko Valtola. (2016) Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma. Expert Review of Hematology 9:8, pages 723-732.
Read now
Read now
Olivier Hequet. (2015) Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility. Journal of Blood Medicine 6, pages 55-67.
Read now
Read now
Craig S. Sauter & Sergio Giralt. (2015) The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies. Leukemia & Lymphoma 56:6, pages 1619-1625.
Read now
Read now
Roberto Crocchiolo, Christian Chabannon, Jean El-Cheikh, Benjamin Esterni, Claude Lemarié, Sabine Fürst, Luca Castagna, Reda Bouabdallah, Patrick Ladaique, Diane Coso, Jean Marc Schiano, Anne Marie Stoppa, Jerome Rey, Vadim Ivanov, Therese Aurran, Catherine Faucher, Didier Blaise & Boris Calmels. (2013) Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma. Leukemia & Lymphoma 54:2, pages 417-420.
Read now
Read now
Louis M Pelus & Sherif S Farag. (2011) Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin’s lymphoma and multiple myeloma. Stem Cells and Cloning: Advances and Applications 4, pages 11-22.
Read now
Read now
Régis Peffault de Latour, Driss Chaoui, Jean-Henri Bourhis, Ramdane Belhocine, Sophie Park, Ollivier Legrand, Philippe Brault, Bernard Rio, F. Heshmati, Sabine Assouad & Didier Decaudin. (2007) Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: A large multicenter comparative study in patients with malignant lymphoma. Leukemia & Lymphoma 48:5, pages 897-904.
Read now
Read now
Articles from other publishers (76)
Jan S. Moreb, Lori Lantos, Franklin Chen, Kathleen Elliott, James Dugan, Alan P. Skarbnik, Patricia Lamont Kropf & Kimberly Ward. (2023) The effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation. Transfusion and Apheresis Science 62:6, pages 103787.
Crossref
Crossref
Eyal Lebel, Katherine Lajkosz, Esther Masih-Khan, Donna Reece, Suzanne Trudel, Rodger Tiedemann, Anca Prica, Vishal Kukreti & Christine Chen. (2023) The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 23:11, pages 850-856.
Crossref
Crossref
Erika S Varady, L Angel Ayala, Pauline U Nguyen, Vanessa M Scarfone, Alborz Karimzadeh, Cuiwen Zhou, Xiyu Chen, Scott A Greilach, Craig M Walsh & Matthew A Inlay. (2023) Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice. EMBO Molecular Medicine 15:9.
Crossref
Crossref
Peipei Ye, Renzhi Pei, Jiaying Lian, Dong Chen, Shuangyue Li, Yixuan Cheng, Fenglin Li, Jiaojiao Yuan, Yao Chen & Ying Lu. (2023) Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients. Cytotherapy 25:8, pages 885-890.
Crossref
Crossref
Leona Holmberg, Michael Linenberger & Laura Connelly-Smith. (2023) Mobilization of Autologous Peripheral Blood Stem Cells (PBSC) in CD20+ Lymphoma Patients Using RICE, Granulocyte-Colony Stimulating Factor (G-CSF) and Plerixafor. OBM Transplantation 07:01, pages 1-15.
Crossref
Crossref
Normann Steiner, Georg Göbel, Leonie Mauser, Lena Mühlnikel, Marie Fischinger, Tina Künz, Wolfgang Willenbacher, Gabriele Hetzenauer, Jakob Rudzki, Walter Nussbaumer, Wolfgang Mayer, Eberhard Gunsilius, Brigitte Kircher, Dominik Wolf & David Nachbaur. (2023) Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study. Cancers 15:3, pages 608.
Crossref
Crossref
Leona A. Holmberg, Michael Linenberger & Laura Connelly-Smith. (2022) Successful Mobilization of Autologous Hematopoietic Peripheral Blood Stem Cells after Salvage Chemotherapy in Patients with Low CD34 Blood Cell Counts. Transplantation and Cellular Therapy 28:11, pages 754-759.
Crossref
Crossref
Srinivasa Reddy Sanikommu, Emily S. Reese, Jiaxian He, Carlos Lee, Jing Ai, Candace M. Butler, Ryan Jacobs, Bei Hu, Shebli Atrash, Jigar Trivedi, Manisha Bhutani, Peter Voorhees, Saad Z. Usmani, Nilanjan Ghosh, Omotayo Fasan, Lawrence J. Druhan, James Symanowski, Edward A. Copelan & Belinda R. Avalos. (2021) Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation. Journal of Clinical Apheresis 36:4, pages 553-562.
Crossref
Crossref
Jian Chen, Hillard M. Lazarus, Parastoo B. Dahi, Scott Avecilla & Sergio A. Giralt. (2021) Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization. Blood Reviews 47, pages 100771.
Crossref
Crossref
Atsushi Marumo, Hiroki Yamaguchi, Tsuneaki Hirakawa, Kazuki Inai, Daishi Onai, Ikuko Omori, Satoshi Yamanaka, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Wakita, Muneo Okamoto, Shunsuke Yui & Koiti Inokuchi. (2021) Presence of Promyelocytes in Peripheral Blood as a Novel Predictor of Optimal Timing for Single-Step Peripheral Blood Stem Cell Collection. Journal of Nippon Medical School 88:1, pages 45-53.
Crossref
Crossref
Anu Partanen, Antti Turunen, Jaakko Valtola, Kaija Vasala, Lasse Ågren, Karri Penttilä, Marja Pyörälä, Taru Kuittinen, Pentti Mäntymaa, Jukka Pelkonen, Esa Jantunen & Ville Varmavuo. (2020)
A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of
CD34
+
cells in
NHL
patients
. Journal of Clinical Apheresis 35:4, pages 255-263.
Crossref
Crossref
Antti Turunen, Anu Partanen, Jaakko Valtola, Antti Ropponen, Timo Siitonen, Outi Kuittinen, Hanne Kuitunen, Mervi Putkonen, Marja Sankelo, Leena Keskinen, Eeva‐Riitta Savolainen, Marja Pyörälä, Taru Kuittinen, Raija Silvennoinen, Karri Penttilä, Anu Sikiö, Kaija Vasala, Pentti Mäntymaa, Jukka Pelkonen, Ville Varmavuo & Esa Jantunen. (2020) CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non‐Hodgkinʼs lymphoma patients: results of the prospective multicenter GOA study. Transfusion 60:7, pages 1519-1528.
Crossref
Crossref
Anna Sureda, Christian Chabannon, Tamás Masszi, David Pohlreich, Christof Scheid, Catherine Thieblemont, Björn E. Wahlin, Ioanna Sakellari, Nigel Russell, Andrea Janikova, Anna Dabrowska-Iwanicka, Cyrille Touzeau, Albert Esquirol, Esa Jantunen, Steffie van der Werf, Paul Bosman, Ariane Boumendil, Qianying Liu, Marina Celanovic, Silvia Montoto & Peter Dreger. (2019) Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor. Bone Marrow Transplantation 55:3, pages 613-622.
Crossref
Crossref
Jack Khouri, Lisa Rybicki, Navneet S. Majhail, Matt Kalaycio, Brad Pohlman, Brian Hill, Deepa Jagadeesh, Robert Dean, Betty Hamilton, Ronald Sobecks, Anna Koo & Hien Liu. (2019) Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation. Journal of Clinical Apheresis 34:6, pages 638-645.
Crossref
Crossref
Leslie A. Andritsos, Ying Huang, Ivo Abraham, Keith Huff, Scott R. Scrape, Tao Fan, Nimer Alkhatib, Craig C. Hofmeister, Edward Drea & Ali McBride. (2019) Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization. Leukemia Research 85, pages 106215.
Crossref
Crossref
Anthony D. Ho. 2019. Stem Cell Mobilization. Stem Cell Mobilization
1
10
.
Mohammad Vaezi, Mohammad Shakouri, Maryam Souri, Mohammad Amin Setaredan, Seyed Asadollah Mossavi, Saeed Mohammadi, Kamran Alimoghaddam & Ardeshir Ghavamzadeh. (2018) The effects of lower CD34 yields after lowe dose G-CSF induction on long-term autologous stem cell transplantation outcome: A single center study. Transfusion and Apheresis Science 57:2, pages 265-271.
Crossref
Crossref
Jan S. Moreb, Michael Byrne, Ilicia Shugarman, Fei Zou, Sican Xiong, William S. May, Maxim Norkin, John Hiemenz, Randall Brown, Christopher Cogle, John R. Wingard & Jack W. Hsu. (2017) Poor peripheral blood stem cell mobilization affects long‐term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation. Journal of Clinical Apheresis 33:1, pages 29-37.
Crossref
Crossref
Jun Zhu, Huiqiang Huang, Huan Chen, Xi Zhang, Zengjun Li, Depei Wu, Daobin Zhou, Yongping Song, Yu Hu, Yingmin Liang, Hanyun Ren, He Huang, Nainong Li, Hu Chen, Jiong Hu, Jianyong Li, Robin Meng, Junlong Wu, Dong Yu & Xiaojun Huang. (2018) Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study. Transfusion 58:1, pages 81-87.
Crossref
Crossref
Binod Dhakal, Lauren Westfall Veltri, Timothy S. Fenske, Daniel Eastwood, Michael D. Craig, Aaron Cumpston, Alexandra Shillingburg, Jean Esselman, Kathy Watkins, Marcelo C. Pasquini, Anita D'Souza, Parameswaran Hari, Abraham Sebastian Kanate & Mehdi Hamadani. (2016) Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation 22:10, pages 1773-1780.
Crossref
Crossref
Marco Aurélio Salvino & Jefferson Ruiz. (2016) Hematopoietic progenitor cell mobilization for autologous transplantation – a literature review. Revista Brasileira de Hematologia e Hemoterapia 38:1, pages 28-36.
Crossref
Crossref
Lauren Veltri, Aaron Cumpston, Alexandra Shillingburg, Sijin Wen, Jin Luo, Sonia Leadmon, Kathy Watkins, Michael Craig, Mehdi Hamadani & Abraham S. Kanate. (2015) Hematopoietic progenitor cell mobilization with “just-in-time” plerixafor approach is a cost-effective alternative to routine plerixafor use. Cytotherapy 17:12, pages 1785-1792.
Crossref
Crossref
Jaakko Valtola, Ville Varmavuo, Antti Ropponen, Anne Nihtinen, Anu Partanen, Kaija Vasala, Päivi Lehtonen, Karri Penttilä, Marja Pyörälä, Taru Kuittinen, Raija Silvennoinen, Tapio Nousiainen, Jukka Pelkonen, Pentti Mäntymaa & Esa Jantunen. (2015) Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison. Transfusion 55:10, pages 2358-2368.
Crossref
Crossref
Cristina Calderón-Cabrera, Magdalena Carmona González, Jesús Martín, Eduardo Ríos Herranz, Pilar Noguerol, Fátima De la Cruz, Estrella Carrillo, Jose F. Falantes, Rocío Parody, Ildefonso Espigado & Jose A. Pérez-Simón. (2015) Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure. Transfusion 55:4, pages 875-879.
Crossref
Crossref
Tamara Girbl, Verena Lunzer, Richard Greil, Konrad Namberger & Tanja Nicole Hartmann. (2014)
The
CXCR
4 and adhesion molecule expression of
CD
34+ hematopoietic cells mobilized by “on‐demand” addition of plerixafor to granulocyte–colony‐stimulating factor
. Transfusion 54:9, pages 2325-2335.
Crossref
Crossref
B M Haverkos, A McBride, L O'Donnell, D Scholl, B Whittaker, S Vasu, S Penza, L A Andritsos, S M Devine & S M Jaglowski. (2014) An effective mobilization strategy for lymphoma patients after failed upfront mobilization with plerixafor. Bone Marrow Transplantation 49:8, pages 1052-1055.
Crossref
Crossref
Ville Varmavuo, Johanna Rimpiläinen, Hanne Kuitunen, Anne Nihtinen, Kaija Vasala, Maija Mikkola, Anu Kutila, Päivi Lehtonen, Taru Kuittinen, Pentti Mäntymaa, Tapio Nousiainen, Outi Kuittinen & Esa Jantunen. (2014) Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients. Transfusion 54:5, pages 1243-1250.
Crossref
Crossref
Hasan Atilla Ozkan, Cengiz Bal & Zafer Gulbas. (2014) Chemomobilization with high-dose etoposide and G-CSF results in effective and safe stem cell collection in heavily pretreated lymphoma patients: report from a single institution study and review. European Journal of Haematology 92:5, pages 390-397.
Crossref
Crossref
Ki Woong SungHee Won ChuehNa Hee LeeDong Hwan KimSoo Hyun LeeKeon Hee YooHong Hoe KooEun Suk KangDae Won Kim. (2014) Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors. Journal of Korean Medical Science 29:1, pages 110.
Crossref
Crossref
Shin Young Hyun, June-Won Cheong, Soo-Jeong Kim, Yoo Hong Min, Deok-Hwan Yang, Jae-Sook Ahn, Won-Sik Lee, Hun-Mo Ryoo, Young Rok Do, Ho Sup Lee, Jae Hoon Lee, Sung Yong Oh, Cheolwon Suh, Ho-Young Yhim & Jin Seok Kim. (2014) High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma. Biology of Blood and Marrow Transplantation 20:1, pages 73-79.
Crossref
Crossref
Jonathan Hoggatt, Tiffany A. Tate & Louis M. Pelus. 2014. Hematopoietic Stem Cell Protocols. Hematopoietic Stem Cell Protocols
43
64
.
Francesco Lanza, Diana C. Campioni, Andrzej Hellmann, Giuseppe Milone, Anders Wahlin, Jan Walewski, Pierangelo Spedini, Cristina Fiamenghi, Antonio Cuneo, Wanda Knopińska, Monica Swierkowska-Czeneszew, Jordi Petriz, Stefan Fruehauf, Dominique Farge, Mohamad Mohty, Jacob Passweg, Tapani Ruuto, Alejandro Madrigal & Hans E. Johnsen. (2013) Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 19:12, pages 1670-1676.
Crossref
Crossref
Jonathan Hoggatt, Jennifer M. Speth & Louis M. Pelus. (2013) Concise Review: Sowing the Seeds of a Fruitful Harvest: Hematopoietic Stem Cell Mobilization. Stem Cells 31:12, pages 2599-2606.
Crossref
Crossref
Aleš Tichopád, Veronika Vítová, Zdeněk Kořístek & Daniel Lysák. (2013) Cost‐effectiveness of hematopoietic stem cell mobilization strategies including plerixafor in multiple myeloma and lymphoma patients. Journal of Clinical Apheresis 28:6, pages 395-403.
Crossref
Crossref
Simone Cesaro, Veronica Tintori, Francesca Nesi, Elisabetta Schiavello, Elisabetta Calore, Sandro Dallorso, Maddalena Migliavacca, Ilaria Capolsini, Raffaella Desantis, Desirèe Caselli, Franca Fagioli, Roberto Luksch, Irene Panizzolo, Gloria Tridello & Arcangelo Prete. (2013) A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients. Transfusion 53:7, pages 1501-1509.
Crossref
Crossref
Abraham S. Kanate, Kathy Watkins, Aaron Cumpston, Michael Craig & Mehdi Hamadani. (2013) Salvage Bone Marrow Harvest in Patients Failing Plerixafor-Based Stem Cell Mobilization Attempt: Feasibility and Autologous Transplantation Outcomes. Biology of Blood and Marrow Transplantation 19:7, pages 1133-1135.
Crossref
Crossref
Seok Jin KimDok Hyun YoonDeok-Hwan YangHyeon Seok EomSeok Goo ChoSung-Soo YoonJae Hoon LeeWon Seog KimCheolwon Suh. (2013) Plerixafor use for peripheral blood stem cell mobilization in Korea. Blood Research 48:2, pages 72.
Crossref
Crossref
Andreas Humpe, Ute Buwitt-Beckmann, Natalie Schub, Martin Gramatzki & Andreas Günther. (2013) Successful Mobilization, Intra-Apheresis Recruitment, and Harvest of Hematopoietic Progenitor Cells by Addition of Plerixafor and Subsequent Large-Volume Leukapheresis. Transfusion Medicine and Hemotherapy 40:4, pages 251-257.
Crossref
Crossref
P. Alvarez, E. Carrillo, C. Vélez, F. Hita-Contreras, A. Martínez-Amat, F. Rodríguez-Serrano, H. Boulaiz, R. Ortiz, C. Melguizo, J. Prados & A. Aránega. (2013) Regulatory Systems in Bone Marrow for Hematopoietic Stem/Progenitor Cells Mobilization and Homing. BioMed Research International 2013, pages 1-12.
Crossref
Crossref
Ivana N.M. Micallef, Shirshendu Sinha, Dennis A. Gastineau, Robert Wolf, David J. Inwards, Morie A. Gertz, Suzanne R. Hayman, William J. Hogan, Patrick B. Johnston, Martha Q. Lacy, Stephen M. Ansell, Francis Buadi, David Dingli, Angela Dispenzieri, Mark R. Litzow, Luis F. Porrata, Jeffrey L. Winters & Shaji Kumar. (2013) Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization. Biology of Blood and Marrow Transplantation 19:1, pages 87-93.
Crossref
Crossref
Nicola Piccirillo, Michele Vacca, Alessandro Lanti, Francesco Ipsevich, Maddalena Maresca, Elena Fiorelli, Maria Bianchi, Gaspare Adorno, Luca Pierelli, Ignazio Majolino, Giuseppe Leone & Gina Zini. (2012) Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. Transfusion and Apheresis Science 47:2, pages 217-221.
Crossref
Crossref
Y. TSUTSUMI, R. OGASAWARA, S. ITO, J. SASAKI, A. MORITA, N. SENOO, N. MURATA, J. TANAKA, M. ASAKA & M. IMAMURA. (2012) Retrospective analysis of an efficient peripheral blood stem cell collection and the relation between infused cell dose and clinical outcome in patients with malignant lymphoma and multiple myeloma. International Journal of Laboratory Hematology 34:4, pages 403-409.
Crossref
Crossref
M E Horwitz, J P Chute, C Gasparetto, G D Long, C McDonald, A Morris, D A Rizzieri, K M Sullivan & N J Chao. (2011) Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration. Bone Marrow Transplantation 47:8, pages 1051-1055.
Crossref
Crossref
Ji‐Won Kim, Hyun Jung Lee, Hyeon Gyu Yi, Byung‐Su Kim, Soo‐Mee Bang, Jin Seok Kim, Inho Kim, Sung‐Soo Yoon, Jong Seok Lee, Chul Soo Kim, Seonyang Park & Byoung Kook Kim. (2012) Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non‐Hodgkin lymphoma. American Journal of Hematology 87:5, pages 479-483.
Crossref
Crossref
A Olivieri, M Marchetti, R Lemoli, C Tarella, A Iacone, F Lanza, A Rambaldi & A Bosi. (2011) Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo. Bone Marrow Transplantation 47:3, pages 342-351.
Crossref
Crossref
A Mahindra, B J Bolwell, L Rybicki, P Elder, M Kalaycio, R Dean, B Avalos, R Sobecks, S Tench, S Andresen, B Pohlman, J Sweetenham, S Devine & E Copelan. (2011) Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia. Bone Marrow Transplantation 47:2, pages 231-235.
Crossref
Crossref
Prakash Vishnu, Vivek Roy, Athena Paulsen & Abba C. Zubair. (2012) Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization. Transfusion 52:1, pages 55-62.
Crossref
Crossref
Stefan Fruehauf & Guido Tricot. 2012. Novel Developments in Stem Cell Mobilization. Novel Developments in Stem Cell Mobilization
165
200
.
J Raschle, D Ratschiller, S Mans, B U Mueller & T Pabst. (2011) High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma. British Journal of Cancer 105:7, pages 970-974.
Crossref
Crossref
S Sinha, D Gastineau, I Micallef, W Hogan, S Ansell, F Buadi, D Dingli, A Dispenzieri, M Gertz, C Greiner, S Hayman, D Inwards, P Johnston, M Lacy, M Litzow, L Porrata, J L Winters & S Kumar. (2010) Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention. Bone Marrow Transplantation 46:7, pages 943-949.
Crossref
Crossref
Mohamad Mohty & Anthony D. Ho. (2011) In and out of the niche: perspectives in mobilization of hematopoietic stem cells. Experimental Hematology 39:7, pages 723-729.
Crossref
Crossref
J E Kim, C Yoo, S Kim, D H Lee, S-W Kim, J-S Lee & C Suh. (2010) Optimal timing of G-CSF administration for effective autologous stem cell collection. Bone Marrow Transplantation 46:6, pages 806-812.
Crossref
Crossref
E Jantunen & S Fruehauf. (2011) Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimens. Bone Marrow Transplantation 46:5, pages 627-635.
Crossref
Crossref
Marianne B. Eide, Grete F. Lauritzsen, Gunnar Kvalheim, Arne Kolstad, Unn M. Fagerli, Martin Maisenhölder, Bjørn Østenstad, Øystein Fluge, Jan Delabie, Harald Aarset, Knut Liestøl & Harald Holte. (2011) High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. British Journal of Haematology 152:5, pages 600-610.
Crossref
Crossref
Jan S. Moreb. (2010) Plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation. Oncology Reviews 5:1, pages 67-73.
Crossref
Crossref
Jan S. Moreb, Donya Salmasinia, Jack Hsu, Wei Hou, Christina Cline & Emma Rosenau. (2011) Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients. Advances in Hematology 2011, pages 1-8.
Crossref
Crossref
John F. DiPersio. (2010) Can every patient be mobilized?. Best Practice & Research Clinical Haematology 23:4, pages 519-523.
Crossref
Crossref
Stefan Fruehauf & Guido Tricot. (2010) Comparison of Unmobilized and Mobilized Graft Characteristics and the Implications of Cell Subsets on Autologous and Allogeneic Transplantation Outcomes. Biology of Blood and Marrow Transplantation 16:12, pages 1629-1648.
Crossref
Crossref
Kazuhiko Kakihana, Kazuteru Ohashi, Hideki Akiyama & Hisashi Sakamaki. (2010) Correlation Between Survival and Number of Mobilized CD34+ Cells in Patients with Multiple Myeloma or Waldenström Macroglobulinemia. Pathology & Oncology Research 16:4, pages 583-587.
Crossref
Crossref
Patrick Wuchter, Dan Ran, Thomas Bruckner, Thomas Schmitt, Mathias Witzens-Harig, Kai Neben, Hartmut Goldschmidt & Anthony D. Ho. (2010) Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation. Biology of Blood and Marrow Transplantation 16:4, pages 490-499.
Crossref
Crossref
John F. DiPersioIvana N. MicallefPatrick J. StiffBrian J. BolwellRichard T. MaziarzEric JacobsenAuayporn NademaneeJohn McCartyGary BridgerGary Calandra. (2009) Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma. Journal of Clinical Oncology 27:28, pages 4767-4773.
Crossref
Crossref
Chitra Hosing, Rima M. Saliba, Sheena Ahlawat, Martin Körbling, Partow Kebriaei, Amin Alousi, Marcos De Lima, Julia‐Grace Okoroji, John McMannis, Muzaffar Qazilbash, Paolo Anderlini, Sergio Giralt, Richard E. Champlin, Issa Khouri & Uday Popat. (2009) Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. American Journal of Hematology 84:6, pages 335-337.
Crossref
Crossref
W Bensinger, J F DiPersio & J M McCarty. (2009) Improving stem cell mobilization strategies: future directions. Bone Marrow Transplantation 43:3, pages 181-195.
Crossref
Crossref
Patrick Stiff, Ivana Micallef, Philip McCarthy, Margarida Magalhaes-Silverman, Daniel Weisdorf, Mary Territo, Karin Badel & Gary Calandra. (2009) Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient. Biology of Blood and Marrow Transplantation 15:2, pages 249-256.
Crossref
Crossref
Douglas A. Stewart, Clayton Smith, Ron MacFarland & Gary Calandra. (2009) Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma. Biology of Blood and Marrow Transplantation 15:1, pages 39-46.
Crossref
Crossref
Cheng Zhang, Xinghua Chen, Xi Zhang, Lei Gao, Peiyan Kong, Qingyu Wang, Xiangui Peng & Hong Liu. (2008) Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex. Transfusion and Apheresis Science 39:1, pages 21-28.
Crossref
Crossref
Rainer Moog. (2008) Management strategies for poor peripheral blood stem cell mobilization. Transfusion and Apheresis Science 38:3, pages 229-236.
Crossref
Crossref
I. H. Park, Y. Kim, J. S. Kim, J.-W. Cheong, J. W. Song & Y. H. Min. (2008) Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies. Transfusion Medicine 18:2, pages 97-103.
Crossref
Crossref
Shirong Wang, Auayporn Nademanee, Dajun Qian, Andrew Dagis, Hyun-Soon Park, Joy Fridey, Eileen Smith, David Snyder, George Somlo, Anthony Stein, Joseph Rosenthal, Peter Falk, Neil Kogut, Joycelynne Palmer, Karl Gaal, Young Kim, Ravi Bhatia, Shan Yuan, Candace Kay, Lawrence Weiss & Stephen Forman. (2007) Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation. Transfusion 47:12, pages 2207-2216.
Crossref
Crossref
M Tomblyn, L J Burns, B Blazar, J Wagner, C Lee, T Rogers, P McGlave, J S Miller & D J Weisdorf. (2007) Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma. Bone Marrow Transplantation 40:2, pages 111-118.
Crossref
Crossref
Karen K. Ballen, Elizabeth J. Shpall, David Avigan, Beow Y. Yeap, David C. Fisher, Kathleen McDermott, Bimalangshu R. Dey, Eyal Attar, Steven McAfee, Marina Konopleva, Joseph H. Antin & Thomas R. Spitzer. (2007) Phase I Trial of Parathyroid Hormone to Facilitate Stem Cell Mobilization. Biology of Blood and Marrow Transplantation 13:7, pages 838-843.
Crossref
Crossref
Felicetto Ferrara, Assunta Viola, Carolina Copia, Ettore Mariano Schiavone, Maria Celentano, Filiberto Pollio, Maria Rosaria D'Amico & Salvatore Palmieri. (2006) Therapeutic results in patients with relapsed diffuse large B cell Non‐Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation. Hematological Oncology 24:2, pages 73-77.
Crossref
Crossref
V Pavone, F Gaudio, G Console, U Vitolo, P Iacopino, A Guarini, V Liso, T Perrone & A Liso. (2006) Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation. Bone Marrow Transplantation 37:8, pages 719-724.
Crossref
Crossref
Ramakrishna L. Reddy. (2005) Mobilization and collection of peripheral blood progenitor cells for transplantation. Transfusion and Apheresis Science 32:1, pages 63-72.
Crossref
Crossref
Mari Endo‐Matsubara, Seishi Ogawa, Ko Sasaki, Tsuyoshi Takahashi, Shigeru Chiba & Hisamaru Hirai. (2004)
Immature granulocyte fraction in the peripheral blood is a practical indicator for mobilization of CD34
+
cells
. American Journal of Hematology 77:3, pages 223-228.
Crossref
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:3, pages 141-148.
Crossref
Crossref